Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients
Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Currently there is no one standard of care for older patients with Non-Hodgkin's Lymphoma
(NHL). The study will examine the tolerability and feasibility to the combination of
Cyclophosphamide, Pegylated Liposomal Doxorubicin, Vincristine, Prednisone (CDOP) plus
Rituximab.